Cleve Clin J Med. 2020 Aug 12. doi: 10.3949/ccjm.87a.ccc057. Online ahead of print.
ABSTRACT
Granulocyte-macrophage colony-stimulating factor (GM-CSF) has been used experimentally in patients with acute respiratory distress syndrome. Recombinant GM-CSF administered by direct inhalation is currently being studied in a cohort of patients with advanced COVID-19.
PMID:32753517 | DOI:10.3949/ccjm.87a.ccc057